Released February 13, 2018 | SUGAR LAND
en
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Industrial Info is pleased to announce the release of the 2018 North America Pharmaceutical & Biotech Industry Outlook. With an industry that encompasses so much, the importance of having a tool that provides understanding and knowledge has never been more essential. Tap into the pulse of the North American Pharmaceutical & Biotech Industry using a clear, concise format that demystifies this lucrative and constantly evolving industry.
The 2018 North America Pharmaceutical & Biotech Industry Outlook provides insight into a market that is anticipating nearly $20 billion worth of North American construction starts in 2018. Each year, Industrial Info provides an overall spending forecast, with the numbers representing total expenditures for capital and maintenance as they relate to the North American Pharmaceutical & Biotech Industry.
The forecast is derived by applying a confidence factor based on historical spending trends to the baseline project activity that Industrial Info is tracking. Industrial Info then uses its project research to analyze the trends as they relate to geography, project type and budget type.
Projects are monitored on a regular basis, providing a "real-time" picture of activity. The dollar amount fluctuates as some project schedules move to different years and entirely new projects are added. The Outlook is updated quarterly to allow for the changes. As of February 2018, the number for potential 2018 kick-offs has already risen to $23 billion. Throughout the year, this number will fluctuate. One month it may hit $24 billion; a few months later, it could drop to $18 billion--that's the nature of Industrial Info's real-time tracking.
The year's projects are measured by the scheduled kickoff date, and each project is valued at $1 million or more. When using the 2018 North America Pharmaceutical & Biotech Industry Outlook, there is no need for the endless searching that often nets too much information that overwhelms rather than informs. Industrial Info has done the homework for you and packaged useful, timely and essential information and statistics into one easy-to-use format. Features include upcoming trends, vital plant and project statistics, and a capital-spending and maintenance-spending analysis derived from Industrial Info's databases.
Setting the outlook apart from any aspiring competitors is that, in addition to having access to its clearly written editorial content, subscribers receive exclusive quarterly updates on 2018 plant and project spending statistics through Industrial Info's online version. Unlike other outlooks or forecasts that offer statistical information, Industrial Info's data is based on phone-verified project and plant information, conducted by an in-house staff of research specialists.
Get the inside edge on your competitors and enjoy an in-house advantage throughout the year by having access to the 2018 North America Pharmaceutical & Biotech Industry Outlook. Current users find the Outlook a perfect companion to Industrial Info's Pharmaceutical-Biotech Industry Platform, which includes reported capital and maintenance projects, as well as operational and pre-commissioned (planned, engineered or under construction) plant profiles, for both manufacturing facilities and laboratories. Industry sectors covered include pharmaceutical and biological manufacturing, diagnostic substances, medicinals and botanicals, cosmetics and medical devices.
In addition to commercial operations, the public sector is included due to its enormous volume of capital spending. Industrial Info's North American Pharmaceutical-Biotech database continues to grow on a nearly daily basis.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com/.
The 2018 North America Pharmaceutical & Biotech Industry Outlook provides insight into a market that is anticipating nearly $20 billion worth of North American construction starts in 2018. Each year, Industrial Info provides an overall spending forecast, with the numbers representing total expenditures for capital and maintenance as they relate to the North American Pharmaceutical & Biotech Industry.
The forecast is derived by applying a confidence factor based on historical spending trends to the baseline project activity that Industrial Info is tracking. Industrial Info then uses its project research to analyze the trends as they relate to geography, project type and budget type.
Projects are monitored on a regular basis, providing a "real-time" picture of activity. The dollar amount fluctuates as some project schedules move to different years and entirely new projects are added. The Outlook is updated quarterly to allow for the changes. As of February 2018, the number for potential 2018 kick-offs has already risen to $23 billion. Throughout the year, this number will fluctuate. One month it may hit $24 billion; a few months later, it could drop to $18 billion--that's the nature of Industrial Info's real-time tracking.
The year's projects are measured by the scheduled kickoff date, and each project is valued at $1 million or more. When using the 2018 North America Pharmaceutical & Biotech Industry Outlook, there is no need for the endless searching that often nets too much information that overwhelms rather than informs. Industrial Info has done the homework for you and packaged useful, timely and essential information and statistics into one easy-to-use format. Features include upcoming trends, vital plant and project statistics, and a capital-spending and maintenance-spending analysis derived from Industrial Info's databases.
Setting the outlook apart from any aspiring competitors is that, in addition to having access to its clearly written editorial content, subscribers receive exclusive quarterly updates on 2018 plant and project spending statistics through Industrial Info's online version. Unlike other outlooks or forecasts that offer statistical information, Industrial Info's data is based on phone-verified project and plant information, conducted by an in-house staff of research specialists.
Get the inside edge on your competitors and enjoy an in-house advantage throughout the year by having access to the 2018 North America Pharmaceutical & Biotech Industry Outlook. Current users find the Outlook a perfect companion to Industrial Info's Pharmaceutical-Biotech Industry Platform, which includes reported capital and maintenance projects, as well as operational and pre-commissioned (planned, engineered or under construction) plant profiles, for both manufacturing facilities and laboratories. Industry sectors covered include pharmaceutical and biological manufacturing, diagnostic substances, medicinals and botanicals, cosmetics and medical devices.
In addition to commercial operations, the public sector is included due to its enormous volume of capital spending. Industrial Info's North American Pharmaceutical-Biotech database continues to grow on a nearly daily basis.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com/.
